CVS raises 2026 outlook, plans split; shares fall 11%

By Tom Whitfield

$2.09 a share: CVS Health's adjusted third-quarter earnings exceeded Wall Street's $1.65 consensus estimate and rose from $1.60 a year earlier. Revenue increased 5.4% to $108.4 billion for the quarter ended Sept. 30, ahead of the $104.75 billion analyst forecast.

The beat underpinned higher 2026 profit and cash targets, yet shares traded 11% lower at $81.44 in Wednesday morning trading. Alongside the results, CVS announced plans to separate into two independent, publicly traded companies, replacing its integrated operating model with a structure scheduled for completion in the first half of 2028.

What changed in the 2026 outlook?

• The full-year adjusted earnings-per-share forecast rose to at least $8.20, compared with $7.90 to $8.10 previously. The new wording sets a floor, not a promised level above it.
• Under generally accepted accounting principles, CVS now forecasts at least $6.98 a share, compared with the previous $6.84 to $7.04 range.
• The operating cash flow forecast increased to at least $15.5 billion from at least $11.5 billion, after CVS generated $15.3 billion through September.

Takeaway: CVS raised both its profit floor and its cash target.

Which businesses drove the improvement?

CVS attributed the higher outlook to improvements in its insurance and pharmacy businesses. Management remained cautious about rising costs and potential economic headwinds, so the new targets still depend on operating gains achieved under a less favorable cost environment.

• Insurance adjusted operating income climbed to $912 million from $314 million a year earlier, primarily reflecting stronger performance in the government business.
• Medical costs fell to 91.3% of premium revenue from 92.8%. Favorable revisions to prior years' health care cost payable estimates totaled $1.3 billion during the first nine months.

Those favorable revisions supported reported performance, but CVS did not say how much of the 2026 forecast depends on further revisions. It also did not quantify how rising costs or economic pressure could change the targets.

Takeaway: Insurance and pharmacy gains support the forecast, but the cost assumptions remain unquantified.

How would the two-company structure work?

CVS's planned separation would mark a shift from its longstanding strategy of combining insurance, pharmacy benefit management and health care services within one organization. Management expects the split to complete in the first half of 2028.

• One company would retain the CVS Health name and house Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.
• The other, CVS Pharmacy, would include approximately 9,000 retail pharmacy locations, MinuteClinic locations and other services.

Management expects the split to give each business "greater independence" while allowing both to pursue "partnerships across the health care industry." That rationale offers strategic flexibility, but it does not prove that separation will improve returns.

CVS did not disclose separation costs, debt allocation, capital structures or post-split leadership arrangements. Those omissions leave financing and execution questions unanswered ahead of the expected 2028 completion.

Takeaway: The blueprint is clear on assets and ownership, but not on the money required to execute it.

Why did the shares fall?

CVS shares were down 11% at $81.44 in Wednesday morning trading. CVS did not identify one catalyst for the decline. The earnings beat and raised outlook supplied positive evidence, while the separation announcement introduced questions about costs and the viability of two standalone businesses.

Without management commentary on investor expectations, any single explanation would overstate the evidence. The supportable conclusion is narrower: the earnings beat did not prevent an 11% decline, and the stock entered the separation process with unresolved execution risks.

Takeaway: The quarter cleared the estimate bar, but separation and cost questions remained unresolved as shares fell.